Use of a pharmaceutically acceptable oxalate derivative in...

Details Use of a pharmaceutically acceptable oxalate derivative in... Use of a pharmaceutically acceptable oxalate derivative in...

A - Human Necessities

61

K

A61K 31/28 (2006.01) A61K 31/19 (2006.01) A61K 31/194 (2006.01) A61K 31/215 (2006.01) A61K 33/24 (2006.01)

Patent

CA 2220687

The invention provides a composition for the treatment of a condition, disorder or a disease of the skin, the autoimmune system or the respiratory tract, or a condition, disorder or disease associated therewith. Preferably, the oxalate is a transition metal oxalate and the pharmaceutically acceptable carrier is an ointment.

L'invention se rapporte à une composition destinée à être utilisée dans le traitement d'affections cutanées, du système auto-immun ou des voies respiratoires, ou d'états, troubles ou pathologies associés. L'oxalate de cette composition est de préférence un oxalate de métaux de transition et l'excipient pharmaceutiquement acceptable est un onguent.

Affiliated with

Also associated with

Rating

Use of a pharmaceutically acceptable oxalate derivative in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a pharmaceutically acceptable oxalate derivative in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a pharmaceutically acceptable oxalate derivative in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1672742